HIV-2 gene product-specific T cell responses and viraemia control od Leligdowicz, A, Yindom, L, Jaye, A, Dong, T, Alabi, A, Sarge-N'jie, R, Njai, H, McMichael, A, Whittle, H, Rowland-Jones, S

CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype od Gillespie, G, Pinheiro, S, Sayeid-Al-Jamee, M, Alabi, A, Kaye, S, Sarge-Njie, R, Njai, H, Joof, K, Jaye, A, Whittle, H, Rowland-Jones, S, Dorrell, L

CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype. od Gillespie, G, Pinheiro, S, Sayeid-Al-Jamee, M, Alabi, A, Kaye, S, Sabally, S, Sarge-Njie, R, Njai, H, Joof, K, Jaye, A, Whittle, H, Rowland-Jones, S, Dorrell, L

Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53. od Dorrell, L, Willcox, B, Jones, E, Gillespie, G, Njai, H, Sabally, S, Jaye, A, DeGleria, K, Rostron, T, Lepin, E, McMichael, A, Whittle, H, Rowland-Jones, S